Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Nat Neurosci ; 20(2): 260-270, 2017 02.
Artículo en Inglés | MEDLINE | ID: mdl-28067904

RESUMEN

The prefrontal cortex helps adjust an organism's behavior to its environment. In particular, numerous studies have implicated the prefrontal cortex in the control of social behavior, but the neural circuits that mediate these effects remain unknown. Here we investigated behavioral adaptation to social defeat in mice and uncovered a critical contribution of neural projections from the medial prefrontal cortex to the dorsal periaqueductal gray, a brainstem area vital for defensive responses. Social defeat caused a weakening of functional connectivity between these two areas, and selective inhibition of these projections mimicked the behavioral effects of social defeat. These findings define a specific neural projection by which the prefrontal cortex can control and adapt social behavior.


Asunto(s)
Conducta Animal/fisiología , Tronco Encefálico/fisiología , Vías Nerviosas/fisiología , Corteza Prefrontal/fisiología , Conducta Social , Animales , Ratones , Ratones Endogámicos C57BL , Modelos Animales , Sustancia Gris Periacueductal/fisiología
2.
Elife ; 52016 08 24.
Artículo en Inglés | MEDLINE | ID: mdl-27557444

RESUMEN

Ras-ERK signalling in the brain plays a central role in drug addiction. However, to date, no clinically relevant inhibitor of this cascade has been tested in experimental models of addiction, a necessary step toward clinical trials. We designed two new cell-penetrating peptides - RB1 and RB3 - that penetrate the brain and, in the micromolar range, inhibit phosphorylation of ERK, histone H3 and S6 ribosomal protein in striatal slices. Furthermore, a screening of small therapeutics currently in clinical trials for cancer therapy revealed PD325901 as a brain-penetrating drug that blocks ERK signalling in the nanomolar range. All three compounds have an inhibitory effect on cocaine-induced ERK activation and reward in mice. In particular, PD325901 persistently blocks cocaine-induced place preference and accelerates extinction following cocaine self-administration. Thus, clinically relevant, systemically administered drugs that attenuate Ras-ERK signalling in the brain may be valuable tools for the treatment of cocaine addiction.


Asunto(s)
Conducta Animal/efectos de los fármacos , Cocaína/administración & dosificación , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Trastornos Relacionados con Sustancias/tratamiento farmacológico , Proteínas ras/antagonistas & inhibidores , Animales , Benzamidas/metabolismo , Péptidos de Penetración Celular/metabolismo , Cuerpo Estriado/efectos de los fármacos , Difenilamina/análogos & derivados , Difenilamina/metabolismo , Ratones
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA